MENU
+Compare
WDNA
ETF ticker: BATS
AS OF
Jul 9 closing price
Price
$14.46
Change
+$0.40 (+2.84%)
Net Assets
2.11M

WDNA stock forecast, quote, news & analysis

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”)... Show more

Category: #Health
WDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for WDNA with price predictions
Jul 09, 2025

WDNA in upward trend: price rose above 50-day moving average on June 03, 2025

WDNA moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for WDNA crossed bullishly above the 50-day moving average on June 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WDNA advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 152 cases where WDNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

WDNA broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), ZOETIS (NYSE:ZTS), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Market Cap

The average market capitalization across the WisdomTree BioRevolution ETF ETF is 40.61B. The market cap for tickers in the group ranges from 64.65K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the WisdomTree BioRevolution ETF ETF was 29%. For the same ETF, the average monthly price growth was 310%, and the average quarterly price growth was 159%. SANA experienced the highest price growth at 39%, while DNA experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the WisdomTree BioRevolution ETF ETF was 5%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 74
Price Growth Rating: 53
SMR Rating: 81
Profit Risk Rating: 82
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
WDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
WisdomTree Trust380 Madison AveNew York
Phone
866-909-9473
Web
www.wisdomtree.com